Michael J. Gerber

2.1k total citations · 1 hit paper
22 papers, 1.5k citations indexed

About

Michael J. Gerber is a scholar working on Pulmonary and Respiratory Medicine, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael J. Gerber has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 4 papers in Neurology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael J. Gerber's work include Pulmonary Hypertension Research and Treatments (5 papers), Hemoglobin structure and function (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Michael J. Gerber is often cited by papers focused on Pulmonary Hypertension Research and Treatments (5 papers), Hemoglobin structure and function (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Michael J. Gerber collaborates with scholars based in United States, Germany and Italy. Michael J. Gerber's co-authors include Lewis J. Rubin, Adaani Frost, Vallerie V. McLaughlin, Michael D. McGoon, Christopher Dufton, Ronald J. Oudiz, Nazzareno Galiè, David B. Badesch, Horst Olschewski and Brian L. Wiens and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Langmuir.

In The Last Decade

Michael J. Gerber

22 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

2008 785 citations Nazzareno Galiè, Horst Olschewski et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Gerber United States	17	1.0k	739	242	154	153	22	1.5k
Pierre Canal France	34	376 0.4×	302 0.4×	83 0.3×	49 0.3×	280 1.8×	138	3.4k
Vito Lorusso Italy	18	277 0.3×	304 0.4×	50 0.2×	31 0.2×	201 1.3×	60	1.9k
Valentina Mercurio Italy	22	490 0.5×	716 1.0×	40 0.2×	62 0.4×	26 0.2×	93	1.4k
Masaki Kawamura Japan	24	283 0.3×	414 0.6×	64 0.3×	111 0.7×	12 0.1×	113	2.0k
Mengqiu Li Norway	20	335 0.3×	391 0.5×	114 0.5×	52 0.3×	27 0.2×	37	2.0k
M Forni France	19	458 0.5×	282 0.4×	88 0.4×	29 0.2×	70 0.5×	39	1.8k
Charles E. Riggs United States	21	261 0.3×	371 0.5×	55 0.2×	96 0.6×	15 0.1×	63	1.6k
Bach Ardalan United States	22	453 0.5×	107 0.1×	65 0.3×	17 0.1×	147 1.0×	105	1.9k
Luis A. Guzmán United States	27	333 0.3×	1.9k 2.5×	38 0.2×	45 0.3×	38 0.2×	57	2.7k
Robert J. Cersosimo United States	16	283 0.3×	109 0.1×	59 0.2×	89 0.6×	35 0.2×	43	1.4k

Countries citing papers authored by Michael J. Gerber

Since Specialization

Citations

This map shows the geographic impact of Michael J. Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Gerber more than expected).

Fields of papers citing papers by Michael J. Gerber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Gerber. The network helps show where Michael J. Gerber may publish in the future.

Co-authorship network of co-authors of Michael J. Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Gerber. A scholar is included among the top collaborators of Michael J. Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Gerber. Michael J. Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galiè, Nazzareno, Horst Olschewski, Ronald J. Oudiz, et al.. (2008). Ambrisentan for the Treatment of Pulmonary Arterial Hypertension. Circulation. 117(23). 3010–3019. 785 indexed citations breakdown →

McGoon, Michael D., Adaani Frost, Ronald J. Oudiz, et al.. (2008). Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities. CHEST Journal. 135(1). 122–129. 132 indexed citations

Gerber, Michael J. & G Ackermann. (2008). OPT-80, a macrocyclic antimicrobial agent for the treatment ofClostridium difficileinfections: a review. Expert Opinion on Investigational Drugs. 17(4). 547–553. 39 indexed citations

Gerber, Michael J., et al.. (2008). Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile. Journal of Medical Microbiology. 57(6). 776–783. 55 indexed citations

Black, Henry R., George L. Bakris, Michael A. Weber, et al.. (2007). Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double‐Blind, Placebo‐Controlled Dose‐Ranging Study. Journal of Clinical Hypertension. 9(10). 760–769. 77 indexed citations

Dufton, Christopher, et al.. (2006). NO CLINICALLY RELEVANT PHARMACOKINETIC INTERACTION BETWEEN AMBRISENTAN AND SILDENAFIL. CHEST Journal. 130(4). 254S–254S. 16 indexed citations

Gerber, Michael J., Christopher Dufton, Helen S. Pentikis, Li Zhu, & Hossein Ardeschir Ghofrani. (2006). AMBRISENTAN HAS NO CLINICALLY RELEVANT EFFECT ON THE PHARMACOKINETICS OR PHARMACODYNAMICS OF WARFARIN. CHEST Journal. 130(4). 256S–256S. 16 indexed citations

Lowes, Brian D., Simon F. Shakar, Marco Metra, et al.. (2005). Rationale and Design of the Enoximone Clinical Trials Program. Journal of Cardiac Failure. 11(9). 659–669. 15 indexed citations

Rubin, Lewis J., Christopher Dufton, & Michael J. Gerber. (2005). Ambrisentan for Pulmonary Arterial Hypertension. Future Cardiology. 1(4). 425–432. 17 indexed citations

10.

Gerber, Michael J. & Lynn M. Walker. (2005). Controlling Dimensions of Polymerized Micelles: Micelle Template versus Reaction Conditions. Langmuir. 22(3). 941–948. 32 indexed citations

11.

Gerber, Michael J., Steven R. Kline, & Lynn M. Walker. (2004). Characterization of Rodlike Aggregates Generated from a Cationic Surfactant and a Polymerizable Counterion. Langmuir. 20(20). 8510–8516. 45 indexed citations

12.

Steffen, Robert, Jean-François Liard, Michael J. Gerber, & Stephen J. Hoffman. (2003). Allosteric Modification of Hemoglobin by RSR13 as a Therapeutic Strategy. Advances in experimental medicine and biology. 530. 249–259. 3 indexed citations

13.

Shaw, Edward, Charles Scott, John H. Suh, et al.. (2003). RSR13 Plus Cranial Radiation Therapy in Patients With Brain Metastases: Comparison With the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database. Journal of Clinical Oncology. 21(12). 2364–2371. 81 indexed citations

14.

Kavanagh, Brian D., Rupert Schmidt‐Ullrich, John D. Roberts, et al.. (2001). A Phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics. International Journal of Radiation Oncology*Biology*Physics. 49(4). 1133–1139. 31 indexed citations

15.

Wahr, Joyce A., Michael J. Gerber, Jürgen Venitz, & Narayan Baliga. (2001). Allosteric Modification of Oxygen Delivery by Hemoglobin. Anesthesia & Analgesia. 92(3). 615–620. 24 indexed citations

16.

Wahr, Joyce A., Michael J. Gerber, Jürgen Venitz, & Narayan Baliga. (2001). Allosteric Modification of Oxygen Delivery by Hemoglobin. Anesthesia & Analgesia. 92(3). 615–620. 24 indexed citations

17.

Huang, Lei, Michael J. Gerber, Jin Lu, & Alan E. Tonelli. (2001). Formation of a flame retardant-cyclodextrin inclusion compound and its application as a flame retardant for poly(ethylene terephthalate). Polymer Degradation and Stability. 71(2). 279–284. 60 indexed citations

18.

Huang, Lei, et al.. (1999). Formation of antibiotic, biodegradable/bioabsorbable polymers by processing with neomycin sulfate and its inclusion compound with ?-cyclodextrin. Journal of Applied Polymer Science. 74(4). 937–947. 26 indexed citations

19.

Doppenberg, E., et al.. (1997). The Rationale for, and Effects of Oxygen Delivery Enhancement to Ischemic Brain in a Feline Model of Human Stroke^a. Annals of the New York Academy of Sciences. 825(1). 241–257. 10 indexed citations

20.

Kavanagh, Brian D., Rupert Schmidt‐Ullrich, John D. Roberts, et al.. (1997). 2179 A phase Ib study to evaluate repeated daily intravenous doses of RSR 13 administered to cancer patients receiving concurrent radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 39(2). 330–330. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact